RSS
General Psychiatry
Research Update
Sertraline in Schizophrenia
Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.
Research Update
Ketamine Fails to Outperform Placebo for Depression in Patients Under Anesthesia
Awais Aftab, MD. Dr. Aftab has no financial relationships with companies related to this material.
Research Update
Mood Switching in Bipolar Disorder
Jesse Koskey, MD. Dr. Koskey has no financial relationships with companies related to this material.
Expert Q&A
A Therapeutic Approach to Schizophrenia
Mark L. Ruffalo, MSW, DPsa.
Editor-in-Chief, The Carlat Psychotherapy Report. Psychotherapist in private practice in Tampa, Florida. Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine.
Dr. Ruffalo has no financial relationships with companies related to this material.
Clinical Update
Lecanemab Breaks Thin Ground in Dementia
Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.
Dr. Aiken has no financial relationships with companies related to this material.
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
